Modulation of metabolic activity of phagocytes by antihistamines
Open Access
- 1 March 2011
- journal article
- Published by Walter de Gruyter GmbH in Interdisciplinary Toxicology
- Vol. 4 (1) , 15-19
Abstract
Modulation of metabolic activity of phagocytes by antihistamines: The purpose of the study was to investigate the effects of H1-antihistamines of the 1stgeneration (antazoline, bromadryl, brompheniramine, dithiaden, cyclizine, chlorcyclizine, chlorpheniramine, clemastine) and the 2ndgeneration (acrivastine, ketotifen, and loratadine) on the respiratory burst of phagocytes. Reactive oxygen species generation in neutrophils isolated from rat blood was measured using luminol-enhanced chemiluminescence. Changes in nitrite formation and iNOS protein expression by RAW 264.7 macrophages were analysed using Griess reaction and Western blotting. The antioxidative properties of drugs in cell-free systems were detected spectrophotometrically, luminometrically, fluorimetrically, and amperometrically. The majority of the H1-antihistamines tested (bromadryl, brompheniramine, chlorcyclizine, chlorpheniramine, clemastine, dithiaden, and ketotifen) exhibited a significant inhibitory effect on the chemiluminescence activity of phagocytes. H1-antihistamines did not show significant scavenging properties against superoxide anion and hydroxyl radical, thus this could not contribute to the inhibition of chemiluminescence. H1-antihistamines had a different ability to modulate nitric oxide production by LPS-stimulated macrophages. Bromadryl, clemastine, and dithiaden were the most effective since they inhibited iNOS expression, which was followed by a significant reduction in nitrite levels. H1-antihistamines had no scavenging activity against nitric oxide. It can be concluded that the effects observed in the H1-antihistamines tested are not mediated exclusively via H1-receptor pathway or by direct antioxidative properties. Based on our results, antihistamines not interfering with the microbicidal mechanisms of leukocytes (antazoline, acrivastine and cyclizine) could be used preferentially in infections. Other antihistamines should be used, under pathological conditions accompanied by the overproduction of reactive oxygen species.Keywords
This publication has 14 references indexed in Scilit:
- Different methods for control and comparison of the antioxidant properties of vegetablesFood Control, 2010
- Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extractsInterdisciplinary Toxicology, 2009
- Histamine H3and H4receptors as novel drug targetsExpert Opinion on Investigational Drugs, 2009
- The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicityInternational Immunopharmacology, 2009
- Continuous electrochemical monitoring of nitric oxide production in murine macrophage cell line RAW 264.7Analytical and Bioanalytical Chemistry, 2009
- Serotonin modulates the oxidative burst of human phagocytes via various mechanismsPlatelets, 2007
- Inhibition of chemiluminescence by carvedilol in the cell‐free system, whole human blood and blood cellsScandinavian Journal of Clinical and Laboratory Investigation, 2005
- Luminol‐, isoluminol‐ and lucigenin‐enhanced chemiluminescence of rat blood phagocytes stimulated with different activatorsLuminescence, 2004
- Molecular pharmacological aspects of histamine receptorsPharmacology & Therapeutics, 1995
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993